Lenalidomide Treatment in Lower Risk Myelodysplastic Syndromes – the experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients)
Source: Leukemia Research - Category: Hematology Authors: Anna Jonasova, Radana Neuwirtova, Helena Polackova, Magda Siskova, Tomas Stopka, Eduard Cmunt, Monika Belickova, Alena Moudra, Lubomir Minarik, Ota Fuchs, Kyra Michalova, Zuzana Zemanova Tags: Research paper Source Type: research
More News: Czechia Health | Hematology | Leukemia | Myelodysplastic Syndrome | Prednisone | Revlimid